SP
BravenNow
Farmer of Pacific Biosciences sells $79,855 in stock
| USA | economy | ✓ Verified - investing.com

Farmer of Pacific Biosciences sells $79,855 in stock

#Farmer #Michele Farmer #Pacific Biosciences #NASDAQ:PACB #stock sale #restricted stock units #tax withholding #Q4 2025 earnings #revenue #share price #under‑valuation #fair value

📌 Key Takeaways

  • Michele Farmer, PACB Chief Accounting Officer, sold 50,167 shares for $79,855 on 17‑18 Feb 2026.
  • Shares were sold to satisfy tax withholding on vested restricted stock units.
  • Sale price averaged $1.576 and $1.629 on 17 and 18 Feb respectively.
  • Post‑sale holdings: 219,092 shares.
  • PACB shares currently trade at $1.68, down 1.75 % weekly but up 32 % over 6 months.
  • PACB’s Q4 2025 earnings beat expectations: loss $0.12 vs. anticipated $0.15; revenue $44.6 m vs. forecast $42.27 m.
  • Analysts consider the stock undervalued based on fair‑value metrics.

📖 Full Retelling

Michele Farmer, Chief Accounting Officer at Pacific Biosciences of California, Inc. (NASDAQ:PACB), sold a total of 50,167 shares of the company’s common stock for roughly $79,855 between 17 and 18 February 2026 to cover tax withholding obligations tied to the vesting of restricted stock units. The sale consisted of 35,215 shares at an average price of $1.576 on 17 February and 14,952 shares at $1.629 on 18 February, with prices ranging from $1.51 to $1.70. The transaction leaves Farmer holding 219,092 shares. PACB’s share price, which stands at $1.68, has fallen 1.75 % over the past week but has risen 32 % over the preceding six months. Despite the recent sale, the company reported stronger-than-expected fourth‑quarter 2025 results, posting a loss per share of $0.12 compared with analysts’ forecast of $0.15, while revenue reached $44.6 million, 5.5 % above the $42.27 million projection. Analysts note that, based on fair‑value calculations, PACB appears undervalued at current levels.

🏷️ Themes

Insider trading, Corporate tax strategy, Stock valuation, Earnings performance, Restricted stock units

Entity Intersection Graph

No entity connections available yet for this article.

Deep Analysis

Why It Matters

Michele Farmer, the chief accounting officer, sold 50,167 shares worth $79,855, indicating a tax-related transaction rather than a strategic divestment. The sale highlights the company's ongoing stock-based compensation program and provides investors with insight into insider activity.

Context & Background

  • Pacific Biosciences (NASDAQ:PACB) is a genomics technology company.
  • The shares were sold at a weighted average price of $1.58 and $1.63 on Feb 17 and 18.
  • The sale was to cover tax withholding on vested restricted stock units.
  • PACB stock has risen 32% over the last six months but fell 1.75% in the past week.
  • The company reported Q4 2025 earnings that beat expectations.

What Happens Next

Investors will watch future earnings releases and any changes in PACB's share-based compensation plans. The company may issue additional shares or adjust its dividend policy, affecting share price volatility.

Frequently Asked Questions

Why did Michele Farmer sell her shares?

She sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Does this sale indicate a lack of confidence in the company?

No, it is a routine tax-related transaction and does not reflect a change in her view of the company.

How many shares does she still own?

After the sale, she directly owns 219,092 shares of PACB.

Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Nvidia and OpenAI close to finalizing smaller, $30 bln investment- FT U.S. stocks end lower after hawkish Fed minutes; Walmart guidance falls short Gold largely flat as investors weigh geopolitical tensions, hawkish Fed minutes Berenberg sees more than 50% upside in this small-cap software stock (South Africa Philippines Nigeria) Farmer of Pacific Biosciences sells $79,855 in stock By Investing.com Insider Trading Published 02/19/2026, 08:38 PM Farmer of Pacific Biosciences sells $79,855 in stock 0 PACB 3.07% Michele Farmer, Chief Accounting Officer at Pacific Biosciences of California, Inc. (NASDAQ:PACB) , sold a total of 50,167 shares of common stock on February 17 and 18, 2026, for approximately $79,855. On February 17, Farmer sold 35,215 shares at a weighted average price of $1.576, with prices ranging from $1.51 to $1.68. Following this, on February 18, she sold 14,952 shares at a weighted average price of $1.629, with prices ranging from $1.55 to $1.70.The stock currently trades at $1.68, down 1.75% over the past week, though shares have gained 32% over the last six months. According to InvestingPro analysis, the company appears undervalued at current levels based on Fair Value calculations. These sales were to cover tax withholding obligations related to the vesting of restricted stock units. Following the transactions, Farmer directly owns 219,092 shares of Pacific Biosciences .For deeper insights into PACB’s financial health and valuation, investors can access a comprehensive Pro Research Report and 12 additional InvestingPro Tips covering the company’s outlook. In other recent news, Pacific Biosciences of California reported its earnings for the fourth quarter of 2025, surpassing analysts’ expectations. The company posted a loss per share of $0.12, which was narrower than the anticipated loss of $0.15, representing a 20% positive surprise. Revenue for the quarter reached $44.6 million, exceeding the...
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine